As a first step towards the clinical use of PSMA-targeted imaging in non-prostate cancer, this feasibility study aimed to assess the feasibility of using [18F]DCFPyL PET/CT imaging to target and visualize primary colon, gastric and pancreatic cancer. This evidence concerns the gene FOLH1 and pancreatic neoplasm.